Programme Anglonordic Biotech Conference V

May 14  

18.30 – 20.00

 Kick-off on the evening before the conference
Drink Reception at the Swedish Ambassador’s Residence in London
   
May 15  
09.00 – 09.30 Registration at DBERR Conference Centre, 1 Victoria Street, London, SW1
09.30 – 09.45

Welcome on behalf of the Chairman of the Conference, Dr Hans Bostrom - Director, Scientific Liaision Scandinavia, MSD and the Ambassador of Denmark, Birger Riis-Jørgensen
09.45 – 10.30

Three Partnering pitches
         - Innate Pharmaceuticals – www.innate.se
         - Diagenic – www.diagenic.com
         - Ipsat Therapies – www.ipsat-ther.com
10.30 – 11.00

Partnering "The London Bus Model" - Wait forever and then two turn up at once! - presented by Merck Sharpe & Dome, Margaret Beer , Senior Director, Scientific Liaison, MSD

11.00 – 12.15 

The Next Thing in Drug Discovery (Panel)
Denmark - Biological complexity challenges drug discovery - CEO and Prof. Ole Thastrup of 2cureX and Univ. of Copenhagen
United Kingdom - Therapeutic Antibodies - Prof. John Landon MD, Chairman and Research Director, MicroPharm Ltd
Sweden - Metabolic Diseases (CVD) - Karo Bio
Norway - The stem cell pathway approach to cancer therapy - Prof. Stefan Krauss of the Norwegian National Hospital
12.15 – 13.30 LUNCH
13.30 – 14.30 

If I knew then what I Know Today (Panel)
Moderator: Chris Gardner, Director, Pharma & Biotech, Citigate Dewe Rogerson
- Three entrepreneurs are interviewed and tell their story
         Peter Samuel Wulff - Co-founder of both Bavarian Nordic A/S and
         NeuroSearch A/S
         Ian Tomlinson - Founder of Domantis
         Kevin Johnson - Chief Executive Officer, PanGenetics BV

14.30 – 14.45

First in Man Studies – regulatory challenges ahead – presented by PhaseOneTrials A/S, Kim Krogsgaard, CEO

14.45 – 15.00  Partnering pitch
         - Clavis Pharma – www.clavispharma.com
15.00 – 15.30 

Pitfalls and How Not to Partner – Sally Shorthose, Partner, Bird & Bird
15.30 – 16.00  How to survive an IPO – Nicholas Johnston, Vice President - EMEA Healthcare, JPMorgan
16.00 – 16.30 'Prove - Build- Scale' - How to create and grow venture-financed companies in a cash-constrained environment - Regina Hodits, Partner, Life Science Group Atlas Venture LLP
16.30 – 16.45  Q&A and Conclusions
16.45 – 19.00   Networking Buffet and Drinks